Anemia

Chapter 4 ANEMIA


Jonathan M. Wong



General Discussion


Anemia is a frequent laboratory abnormality in children, affecting as many as 20% of children in the United States and as many as 80% of children in developing countries. Anemia is defined as a decreased concentration of hemoglobin and red blood cell (RBC) mass compared with age-matched controls. Age-specific blood cell indices are outlined below in Table 4-1.



The physiologic anemia of infancy is often confused with a pathologic condition. During the first weeks of life, erythropoietin synthesis abruptly decreases, resulting in a relative anemia. In the ensuing 6 to 8 weeks, the hemoglobin reaches a low point of 9 to 11 g/dL in term infants. The hemoglobin may reach a low point of 7 to 9 g/dL in premature infants. Erythropoietin production is then stimulated, and the hemoglobin level returns to normal. This physiologic anemia does not require work-up unless it is lower than the expected range.


Anemia varies with sex as well as race. African-American children have a lower normal value than their Caucasian counterparts, and glucose-6-phosphate dehydrogenase (G6PD) deficiency is far more common in male than in female children.


Most children with anemia are asymptomatic and have an abnormal hemoglobin level detected at routine screening. A child may present with pallor, fatigue, or jaundice if the anemia is severe or acute.


Anemia usually results from decreased production of RBCs, increased destruction of RBCs, or blood loss. Erythropoietin is the main hormonal regulator of RBC production. In the fetus, it comes from the monocyte/macrophage system of the liver, and postnatally is produced in the peritubular cells of the kidneys.



Jun 18, 2016 | Posted by in PEDIATRICS | Comments Off on Anemia

Full access? Get Clinical Tree

Get Clinical Tree app for offline access